Google
Trusted Resources: News & Events
Latest announcements and gatherings
Young Sickle Cell Patients Who Don’t Take Medication Have Lower Quality of Life
Adolescents and young adults with sickle cell disease (SCD) who don’t regularly take the medication hydroxyurea (or who don’t adhere to prescribed instructions) are generally those with medication-taking barriers such as forgetfulness, lack of access, poor medication knowledge, fear of side effects, or doubts about the drug’s treatment, according to new research. Patients with more barriers to taking their medication tended to have a lower quality of life.
The study, “Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease,” was published online in the European Journal of Haematology. The researchers focused on clarifying the relationship between these barriers and quality of life for SCD patients.
+myBinderRelated Content
-
Opioid use is not associated with in-hospital mortality among patients with sickle cell disease in the United StatesBackground: Vaso-occlusive pain crises ...
-
Santonio Holmes’ Strikes Against Sickle Cell Bowlathon – A star-studded celebrationSantonio Holmes, right, and Roosevelt Ni...
-
HABIT Efficacy and Sustainability Trial, a Multi-Center Randomized Controlled Trial to Improve Hydroxyurea Adherence...Background: Hydroxyurea (HU) is recomme...
-
Today’s Faces of Sickle Cell Disease: Jeffrey ZuttahJeffrey Zuttah, 33, is a patient advoc...
-
Patient Perspective: Childhood Experiences of Sickle Cellhttps://www.youtube.com/watch?v=982zM-s4...
-
Kyriako Damavoletes Talks About the Stigma of Sickle Cell DiseaseKyriako Damavoletes has HbS beta thalass...
-
The Cellie Coping Kit helps sick kids manage the stress of treatmentDesigned by Marsac during her fellowship...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.